Europe — EMA

Onivyde Pegylated Liposomal (Irinotecan)

Irinotecan, the active ingredient in Onivyde Pegylated Liposomal, is a topoisomerase I inhibitor presented as a sterile lyophilized powder for intravenous infusion use.

Irinotecan

Request sourcing

Pack/s

What is Irinotecan?

Irinotecan, the active ingredient in Onivyde Pegylated Liposomal, is a topoisomerase I inhibitor presented as a sterile lyophilized powder for intravenous infusion use. It is employed in the treatment of metastatic metastatic colorectal cancer in adults. GNH USA supplies Onivyde Pegylated Liposomal as a licensed, GDP‑compliant international pharmaceutical supplier serving oncology centres worldwide.

GNH USA supplies Onivyde Pegylated Liposomal as a licensed, GDP‑compliant international pharmaceutical supplier serving oncology centres worldwide.

What is Irinotecan used for?

Onivyde Pegylated Liposomal is a liposomal formulation of irinotecan that  …

- Col ...

What are the side effects of Irinotecan?

Common

Frequently asked questions

...

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →